| Facilities / Instruments | Tenure | Amount ( ₹ Crore) | Rating | Rating Action | Regulator |
|---|---|---|---|---|---|
| Fund Based | Long Term | 35.16 | BWR BBB - /Stable | Assignment | RBI |
| Short Term | 12.00 | BWR A3 | Assignment | RBI | |
| Non Fund Based | Long Term | 2.75 | BWR BBB - /Stable | Assignment | RBI |
| Total | 49.91 | ||||
Brickwork Ratings has assigned the long-term rating of BWR BBB-/Stable and the short-term rating of BWR A3 for the bank loan facilities aggregating to Rs. 49.91 Crs of Savelife Institute of Medical Sciences Pvt. Ltd.
For assigning the ratings, BWR has relied on the audited financials for FY24 and FY25, provisional financials for FY26 and projected financials for FY27-FY28 of the company, and clarification provided by the company.
The rating derives strength from the experienced promoters with established medical expertise, modern hospital infrastructure, improving scale of operations, increasing patient footfall, empanelment with TPAs/CGHS, and improving financial performance support the rating. The company has also demonstrated healthy operating performance and an established presence in the healthcare segment.
The ‘Stable’ outlook indicates a low likelihood of rating change over the medium term. BWR believes Savelife Institute of Medical Sciences Pvt. Ltd.’s business and financial risk profile will be maintained over the medium term. The outlook may be revised to Positive if a sustained increase in the scale of operations and higher-than-envisaged profitability result in an improved financial risk profile, leading to stronger cash accruals and improved leverage. The outlook may be revised to Negative if lower-than-expected revenue or profitability, deterioration in leverage indicators, or any stress in servicing debt obligations occur.
KEY COVENANTS OF THE INSTRUMENT/FACILITYThe terms of the sanction include standard covenants normally stipulated for such facilities.
ANALYTICAL APPROACH & APPLICABLE RATING CRITERIA| Analytical Approach | Comments |
|---|---|
| Applicable Rating Criteria | |
| Parent/Group/Government Support | NA |
|
Analytical Approach (Standalone) |
BWR has considered the standalone performance of the company. |
The company has witnessed an improvement in profitability, with management indicating continued growth in profits during the current financial year, which is expected to support the overall financial profile.
Presence across various medical specialties supports diversification in revenue streams and reduces dependence on a single specialty.
The hospital is supported by a team of experienced doctors and medical professionals across various specialties, which supports the quality of healthcare services and helps in maintaining patient confidence.
Faces competition from established multi-speciality hospitals and needs continuous investment in doctors, technology and infrastructure
The hospital's operating performance remains dependent on maintaining adequate patient footfall and occupancy levels to support revenue generation and profitability.
Positive Triggers:
A sustained improvement in the scale of operations, with TOI sustained above Rs. 150 crore, supported by healthy patient occupancy and improvement in operating profitability.
Strengthening of debt protection metrics, with net margin sustained above 20%, DSCR above 3.10x, and moderation in leverage (Total Debt/TNW below 1.40x).
Negative Triggers:
TOI remaining below Rs. 35 crore, coupled with a significant decline in operating margins or weakening in profitability.
DSCR below 1.2x on a sustained basis, or Total Debt/TNW increasing above 2.5x.
Significant increase in working capital requirements or deterioration in liquidity, adversely impacting the company's overall credit risk profile.
LIQUIDITY POSITION - Adequate
Bank limit utilization averaged 43.96% during the past 12 months ended 18 September 2026. Gross cash accruals are Rs. 10.68 crores annually, which is more than adequate against the yearly repayment obligations of 4.27 Crores in FY 26. The current ratio is around 0.67 times; the ISCR and DSCR ratios of the company stand at 5.55 times and 1.67 times as of March 31, 2026.
ENVIRONMENTAL, SOCIAL, GOVERNANCE (ESG) PRACTICESThe company's ESG profile demonstrates an evolving profile across environmental, social, and governance dimensions, aligned with the operational characteristics of the services sector.
Environmental: The company focuses on complying with applicable environmental regulations for healthcare facilities, including biomedical waste management through authorized agencies and adherence to statutory environmental norms. Further, no material environmental non-compliance or penalties were reported
Social: Ensuring the safety and well-being of patients, staff, and the community is paramount in healthcare waste management. By prioritizing proper handling procedures, facilities can significantly reduce the risk of spreading infections and diseases. To achieve this, it is essential to conduct regular training and awareness programs for healthcare staff that focus on effective waste segregation and disposal. Employee capability development remains a priority, supported by training programmes and structured career progression initiatives.
Governance: Governance considerations highlight the institution’s adherence to regulatory and ethical standards.
COMPANY / FIRM PROFILE| Industry Classification | |||
|---|---|---|---|
| Macro Economic Indicator | Sector | Industry | Basic Industry |
| Healthcare | Healthcare | Healthcare Services | Hospital |
Save Life Institute of Medical Sciences Private Limited was incorporated in October 2021 under the Companies Act, 2013, with Dr. Vijay Kumar Gupta and Ms. Mamta Gupta as founding directors. The leadership team was subsequently expanded with the appointment of Dr. Utkarsh Gupta and Dr. Shobhita Gupta to the Board of Directors.
The entity operates a multi-specialty facility located at DLF Skycourt, Sector 87, Gurugram. It offers full-scale tertiary care, providing comprehensive medical and surgical services across more than eight super-specialties.
The facility is NABH-accredited and aligns its care protocols with the WHO Patient Safety Guidelines. Additionally, the hospital is empanelled with major government healthcare schemes—including CGHS, ECHS, ESIC, and the Haryana Government—enabling accessible healthcare coverage for eligible beneficiaries and government employees.
| Standalone Financial Indicators (in ₹ crore) | Units | FY 23 - 24 (A) | FY 24 - 25 (A) | FY 25 - 26 (P) |
|---|---|---|---|---|
| Operating Revenue | Rs.Crs. | 13.60 | 21.67 | 34.07 |
| EBITDA | Rs.Crs. | 4.53 | 7.04 | 12.29 |
| PAT | Rs.Crs. | 0.08 | 3.17 | 7.28 |
| Tangible Net Worth | Rs.Crs. | 7.95 | 11.12 | 18.40 |
| Total Debt / Tangible Net Worth | Times | 4.64 | 3.48 | 2.26 |
| Current Ratio | Times | 0.22 | 0.31 | 0.67 |
|
* A:Audited UA:Unaudited P:Provisional PROJ:Projected
|
||||
|
Note: These are latest available financial results. All ratios as per BWR's calculations; Amount in ₹ crore
|
||||
| Current Rating (2026) | Rating History | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | |||||||
| Facility / Instrument | Type | Amount ( ₹ Crore) |
Rating | Date | Rating | Date | Rating | Date | Rating |
| Fund Based | LT | 35.16 |
BWR BBB-/Stable
(Assignment) |
NA |
NA
|
NA |
NA
|
NA |
NA
|
| Fund Based | ST | 12.00 |
BWR A3
(Assignment) |
NA |
NA
|
NA |
NA
|
NA |
NA
|
| Non Fund Based | LT | 2.75 |
BWR BBB-/Stable
(Assignment) |
NA |
NA
|
NA |
NA
|
NA |
NA
|
| Grand Total | 49.91 | (Rupees Forty Nine Crores and Ninety One lakhs Only) | |||||||
| Instrument / Facility | Complexity Indicator |
|---|---|
| Fund Based | Simple |
| Non Fund Based | Simple |
The Complexity Indicator refers to the ease with which the returns associated with the rated instrument could be estimated. It does not indicate the risk related to the timely payments on the instrument, which is rather indicated by the instrument's credit rating. It also does not indicate the complexity associated with analysing an entity's financial, business, industry risks or complexity related to the structural,transactional or legal aspects. Details on the complexity levels of the instruments are available on BWR's website Complexity Levels.
NON-COOPERATION WITH PREVIOUS CREDIT RATING AGENCYNot Applicable
| Contacts | |
|---|---|
|
Analyst Team Contact
Shyam Sunder Narang shyam.n@brickworkratings.com Divyanshu Pandey Analyst divyanshu.p@brickworkratings.com |
Relationship Contact
Abhinandan Sarda Senior Director - Business Development abhinandan.s@brickworkratings.com Client Support clientsupport@brickworkratings.com |
| SL.No. | Name of Bank | Facilities | Tenor | Amount ( ₹ Crore) | Regulator |
|---|---|---|---|---|---|
| 1 | HDFC Bank | Term LoanProposed | Long Term | 12.00 | RBI |
| 2 | HDFC Bank | Working Capital Term LoanSanctioned | Long Term | 17.17 | RBI |
| 3 | HDFC Bank | Working Capital Term LoanSanctioned | Long Term | 0.28 | RBI |
| 4 | HDFC Bank | Working Capital Term LoanSanctioned | Long Term | 1.66 | RBI |
| 5 | HDFC Bank | Working Capital Term LoanSanctioned | Long Term | 4.05 | RBI |
| 6 | HDFC Bank | Working Capital Term LoanSanctioned | Long Term | _ | RBI |
| 7 | HDFC Bank | Over DraftSanctioned | Short Term | 6.00 | RBI |
| 8 | HDFC Bank | Over DraftProposed | Short Term | 6.00 | RBI |
| 9 | HDFC Bank | Bank GuaranteeSanctioned | Long Term | 2.25 | RBI |
| 10 | HDFC Bank | Bank GuaranteeProposed | Long Term | 0.50 | RBI |
| Total | 49.91 | ||||
| Name of the Instrument/Facility | Long Term/Short Term | ISIN | Date of Issuance | Coupon Rate (%) | Maturity Date | Size of the Issue ( ₹ Crore) | Rating Assigned and Rating Outlook th> | Regulator |
|---|---|---|---|---|---|---|---|---|
| Nil | Nil | Nil | Nil | Nil | Nil | Nil | Nil | Nil |
| Name of Entity | % Ownership | Extent of consolidation | Rationale for consolidation |
|---|---|---|---|
| Nil | Nil | Nil | Nil |
| A. | Rating activities | |
|---|---|---|
| SL.No. | Instrument / Activity | Regulator of the Instruments |
| 1 | Listed/Proposed to be listed bonds/debentures/preference share (all securities) | SEBI |
| 2 | Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share (all securities) | MCA |
| 3 | Listed PTCs / Securitisation Notes (originated by entities regulated by RBI)* $ | RBI |
| 4 | Listed PTCs / Securitisation Notes (originated by entities not regulated by RBI)* | SEBI |
| 5 | Unlisted PTCs / Securitisation Notes (originated by entities regulated by RBI)* | RBI |
| 6 | Listed Commercial Paper and NCDs with original maturity less than 1 year | RBI |
| 7 | Unlisted Commercial Paper and NCDs with original maturity less than 1 year | RBI |
| 8 | Loan Facilities (Fund/Non-Fund Based) from Bank/NBFCs/NHB/FIs^ | RBI |
| 9 | External Commercial Borrowings and other similar borrowings | RBI |
| 10 | Certificates of Deposit | RBI |
| 11 | Fixed Deposits raised by NBFCs,HFCs, FIs | RBI |
| 12 | Fixed Deposits raised by corporates other than NBFCs, Banks, HFCs, FIs | MCA |
| 13 | Inter Corporate Deposits/Loans extended by Corporates | MCA |
| 14 | Borrowing programme ~ | - |
| 15 | Issuer Ratings # | - |
| 16 | Credit Ratings for Capital Protection Oriented Schemes (by Mutual Funds and AIFs) | SEBI |
| 17 | Credit Quality Ratings (CQR) for Mutual Fund Schemes and Schemes of AIFs | SEBI |
| 18 | Listed Security Receipts $ | RBI |
| 19 | Unlisted Security Receipts | RBI |
| 20 | Independent Credit Evaluation (ICE) | RBI |
| 21 | Expected Loss Ratings (Listed/Proposed to be listed bonds/debentures/preference share (all securities)) | SEBI |
| 22 | Expected Loss Ratings (Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share (all securities)) | MCA |
| 23 | Unlisted PTCs / Securitisation Notes (originated by entities not regulated by RBI) * | Investor-side regulator such as IRDAI, PFRDA @ |
* Includes securitisation transactions involving assignee payout, acquirer's payout.
~ The rated instrument may involve issuance of different instruments such as debt securities (listed or otherwise), bank loans,
commercial paper (listed or otherwise), etc. The regulator of the instrument may accordingly be SEBI, RBI or MCA and can only be
determined upon issuance. In PRs subsequent to issuance(s), Brickwork Ratings India Private Limited (BWR) shall separately capture the rated quantum
details along with names of respective regulators.
^ Includes bank facilities such as liquidity facility, second loss facility that are part of securitisation transactions.
# There is no instrument being rated and hence, Regulator of the Instrument is not applicable. The rating scale and definitions are
being followed as stipulated in SEBI Master Circular for CRAs.
@ These ratings were assigned during regulatory regime prior to introduction of SEBI CRA Circular dated Feb 10, 2026 and the
investor side regulators have accordingly been included.
$ By virtue of the instrument being listed, SEBI acts as the regulator for listing and related issues.
Note: Kindly note that for activities or instruments falling under the purview of FSRs other than SEBI, the grievance/dispute
redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
| B. | Other Activities | Regulator of the Instruments |
|---|---|---|
| 1 | Monitoring Agencies | SEBI |
| 2 | Research activities incidental to rating such as research for Economy, Industries and Companies * | NA |
BWR Board of Directors have no influence over rating decisions, nor do they sit on the rating committee or review, discuss or evaluate any credit rating during the Board meetings.
About Brickwork Ratings
Brickwork Ratings (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by Reserve Bank of India [RBI]. BWR is the 5th agency to get a credit rating registration in India in 2009 and its corporate office in Bengaluru. It has a country-wide presence with representatives in 150+ locations. Canara bank is an institutional investor in Brickwork.
Brickwork offers credit ratings of Bank Loan, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitisation Products, Municipal Bonds, etc. BWR has also rated NGOs, Educational Institutions, Hospitals, Urban Local Bodies and Municipal Corporations.
Nature of Ratings & Information: BWR ratings are opinions on the relative ability of an entity/instrument to meet its financial obligations and are based on information obtained from issuers and other sources believed to be reliable. BWR does not conduct audits, due diligence, or independent verification of such information and does not guarantee its accuracy, adequacy, or completeness.Ratings are current only as of the date of publication and may be revised based on new or unavailable information.
No Advice or Recommendation: Ratings, reports, and related communications are not investment advice and do not constitute recommendations to buy, sell, or hold securities, or to sanction, renew, or disburse credit facilities. They do not represent offers or solicitations for any transaction. Users must rely on their own independent judgment and professional advice. Access to or use of these materials does not create any client relationship with BWR.
Liability, Usage & Regulatory Framework: This content is published for the purpose of dissemination of information as required under applicable laws and regulations. BWR holds exclusive copyright over the content. It may be used with appropriate credit to BWR, provided that the content is not altered or modified in any way that could change its meaning or intent. BWR retains the exclusive right to distribute or share its rating rationales, directly or indirectly, through any print, digital, or electronic media. All reports are provided on an "as is" basis without warranties of any kind, express or implied, including but not limited to merchantability, fitness for a particular purpose, or non-infringement. BWR and its affiliates shall not be liable for any direct, indirect, incidental, or consequential losses or damages arising from the use of these reports. Ratings are subject to continuous surveillance and may be revised, suspended, or withdrawn at any time without notice. These reports are intended for use within India only. BWR operates under SEBI Regulations and Code of Conduct.
For more information on policies and ratings, please visit our www.brickworkratings.com